staurosporine aglycone has been researched along with Leukemia P388 in 2 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pereira, ER | 1 |
Belin, L | 1 |
Sancelme, M | 1 |
Prudhomme, M | 1 |
Ollier, M | 1 |
Rapp, M | 1 |
Sevère, D | 1 |
Riou, JF | 1 |
Fabbro, D | 1 |
Meyer, T | 1 |
Horton, PA | 1 |
Longley, RE | 1 |
McConnell, OJ | 1 |
Ballas, LM | 1 |
2 other studies available for staurosporine aglycone and Leukemia P388
Article | Year |
---|---|
Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacillus cereus; Carbazoles; Escherichia coli | 1996 |
Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian, Eudistoma sp.
Topics: Africa, Western; Animals; Antineoplastic Agents; Carbazoles; Cell Adhesion; Cell Division; Humans; I | 1994 |